1 completed, 1 withdrawn. 2 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 2 | Completed 1, Withdrawn 1 |
Follow Recurrent Gliosarcoma: new trials by email Literature Review of Recurrent Gliosarcoma trials Research Report on Recurrent Gliosarcoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Inducing a Hypothyroxinemic State in Patients With Recurrent Glioblastoma or Gliosarcoma Liothyronine, Lomustine, Methimazole - Recurrent Glioblastoma, Recurrent Gliosarcoma | Early Phase 1 | Withdrawn | Emory University | 2021-10-20 | 2022-12-02 | |
| Vaccine Therapy in Treating Patients With Recurrent Glioblastoma Laboratory Biomarker Analysis, Malignant Glioma Tumor Lysate-Pulsed Autologous Dendritic Cell Vaccine - Giant Cell Glioblastoma, Recurrent Glioblastoma | Early Phase 1 | Completed | Mayo Clinic | 20 | 2013-11-27 | 2023-06-28 |
Glioblastoma (2) · Gliosarcoma (2)
Astrocytoma (2) · Glioma (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Neoplasms, Germ Cell and Embryonal (2) · Neoplasms, Glandular and Epithelial (2) · Neoplasms, Nerve Tissue (2) · Neoplasms, Neuroepithelial (2) · Neuroectodermal Tumors (2)
Lomustine (1) · Methimazole (1) · Triiodothyronine (1)
Emory University (1) · Mayo Clinic (1)
United States (1)
Ian Parney (1) · Jeffrey J. Olson, MD (1)
P30CA138292 (1)